Radioimmunotherapy-induced intratumoral changes in cervical squamous cell carcinoma at single-cell resolution.
作者信息
Liu Chao, Yu Hao, Huang Rui, Lei Tianyu, Li Xiaohui, Liu Ming, Huang Qingyu, Du Qilian, Xing Ligang, Yu Jinming
机构信息
Department of Radiation Oncology and Shandong Provincial Key Laboratory of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, 250117, P. R. China.
Research Unit of Radiation Oncology, Chinese Academy of Medical Sciences, Jinan, Shandong, 250117, P. R. China.
出版信息
Cancer Commun (Lond). 2022 Dec;42(12):1407-1411. doi: 10.1002/cac2.12342. Epub 2022 Jul 27.
Abstract
摘要
相似文献
1
Radioimmunotherapy-induced intratumoral changes in cervical squamous cell carcinoma at single-cell resolution.
Cancer Commun (Lond). 2022 Dec;42(12):1407-1411. doi: 10.1002/cac2.12342. Epub 2022 Jul 27.
2
Radioimmunotherapy and apoptotic induction on CK19-overexpressing human cervical carcinoma cells with Re-188-mAbCx-99.
Anticancer Res. 2005 Jul-Aug;25(4):2719-28.
3
[The comparison of radiosensitivity between uterine cervical squamous carcinoma and adenocarcinoma].
Zhonghua Fu Chan Ke Za Zhi. 1998 Oct;33(10):611-3.
4
Biological properties and radiation responses of the hamster uterine cervical squamous cell carcinoma.
Radiat Res. 1979 Mar;77(3):561-76.
5
[Pathological study of radiation therapy on uterine cervical carcinoma (I) (author's transl)].
Rinsho Hoshasen. 1978 Aug;23(8):901-2.
6
[Organ specificity of carcinoma originating from stratified epithelium and its treatment (9). Radiotherapy of cancer of the uterine cervix].
Gan No Rinsho. 1969 Mar;15(3):310-5.
7
Cervical carcinoma: relationship between histology and survival following radiation therapy.
Obstet Gynecol. 1970 Mar;35(3):339-43.
8
Association between uterine prolapse and cervical squamous cell carcinoma in an elderly adult.
J Am Geriatr Soc. 2012 Sep;60(9):1775-7. doi: 10.1111/j.1532-5415.2012.04139.x.
9
[Results and prognostic factors in cancer of the uterine cervix].
Rev Chil Obstet Ginecol. 1985;50(2):113-26.
10
Radiation-induced early changes in size and vascularity of cervical carcinoma. A colpophotographic and clinical study.
Acta Radiol Diagn (Stockh). 1967:Suppl 274:7+.
引用本文的文献
1
Folate metabolism-associated CYP26A1 is a clinico-immune target in colorectal cancer.
Genes Immun. 2025 Jul 3. doi: 10.1038/s41435-025-00342-6.
2
A Multifunctional Fe-EGCG@RSL3 Nanomedicine Synergizes Ferroptosis Induction and Tumor Microenvironment Remodeling for Enhanced Bladder Cancer Immunotherapy.
Research (Wash D C). 2025 Jun 17;8:0735. doi: 10.34133/research.0735. eCollection 2025.
3
Single-cell transcriptomic analysis deciphers the inflammatory microenvironment characterized by CXCL9+ fibroblasts and ACKR1+ endothelial cells in immune-related myocarditis.
J Transl Med. 2025 May 16;23(1):555. doi: 10.1186/s12967-025-06551-x.
4
Single-cell multi-omics analysis identifies SPP1 macrophages as key drivers of ferroptosis-mediated fibrosis in ligamentum flavum hypertrophy.
Biomark Res. 2025 Feb 25;13(1):33. doi: 10.1186/s40364-025-00746-6.
5
Role of CD4 T cells in cancer immunity: a single-cell sequencing exploration of tumor microenvironment.
J Transl Med. 2025 Feb 14;23(1):179. doi: 10.1186/s12967-025-06167-1.
6
Unravelling immune microenvironment features underlying tumor progression in the single-cell era.
Cancer Cell Int. 2024 Apr 22;24(1):143. doi: 10.1186/s12935-024-03335-z.
7
The abscopal effect of immune-radiation therapy in recurrent and metastatic cervical cancer: a narrative review.
Front Immunol. 2023 Jul 19;14:1201675. doi: 10.3389/fimmu.2023.1201675. eCollection 2023.
8
Single-cell dissection of cellular and molecular features underlying human cervical squamous cell carcinoma initiation and progression.
Sci Adv. 2023 Jan 27;9(4):eadd8977. doi: 10.1126/sciadv.add8977.
本文引用的文献
1
Low-Dose Radiotherapy Reverses Tumor Immune Desertification and Resistance to Immunotherapy.
Cancer Discov. 2022 Jan;12(1):108-133. doi: 10.1158/2159-8290.CD-21-0003. Epub 2021 Sep 3.
2
Neoadjuvant durvalumab with or without stereotactic body radiotherapy in patients with early-stage non-small-cell lung cancer: a single-centre, randomised phase 2 trial.
Lancet Oncol. 2021 Jun;22(6):824-835. doi: 10.1016/S1470-2045(21)00149-2. Epub 2021 May 18.
3
Heterogeneity of IFN-Mediated Responses and Tumor Immunogenicity in Patients with Cervical Cancer Receiving Concurrent Chemoradiotherapy.
Clin Cancer Res. 2021 Jul 15;27(14):3990-4002. doi: 10.1158/1078-0432.CCR-20-4521. Epub 2021 Mar 25.
4
Targeting tumor-associated macrophages to synergize tumor immunotherapy.
Signal Transduct Target Ther. 2021 Feb 23;6(1):75. doi: 10.1038/s41392-021-00484-9.
5
Current Status of Clinical Trials for Cervical and Uterine Cancer Using Immunotherapy Combined With Radiation.
Int J Radiat Oncol Biol Phys. 2021 Feb 1;109(2):396-412. doi: 10.1016/j.ijrobp.2020.09.016. Epub 2020 Sep 15.
6
Immunotherapy With Radiotherapy and Chemoradiotherapy for Cervical Cancer.
Semin Radiat Oncol. 2020 Oct;30(4):273-280. doi: 10.1016/j.semradonc.2020.05.003.
7
Final Analysis of the Ipilimumab Versus Placebo Following Radiotherapy Phase III Trial in Postdocetaxel Metastatic Castration-resistant Prostate Cancer Identifies an Excess of Long-term Survivors.
Eur Urol. 2020 Dec;78(6):822-830. doi: 10.1016/j.eururo.2020.07.032. Epub 2020 Aug 15.
8
Enhanced tumor response to radiotherapy after PD-1 blockade in metastatic gastric cancer.
Gastric Cancer. 2020 Sep;23(5):893-903. doi: 10.1007/s10120-020-01058-4. Epub 2020 Mar 16.
9
Decreased local immune response and retained HPV gene expression during chemoradiotherapy are associated with treatment resistance and death from cervical cancer.
Int J Cancer. 2020 Apr 1;146(7):2047-2058. doi: 10.1002/ijc.32793. Epub 2019 Dec 4.
10
Optimising efficacy and reducing toxicity of anticancer radioimmunotherapy.
Lancet Oncol. 2019 Aug;20(8):e452-e463. doi: 10.1016/S1470-2045(19)30171-8. Epub 2019 Jul 29.
Zotero 插件